Podcasts about Optum

Nick is a rider who proves that passion, persistence, and maybe a touch of stubbornness can take you pretty far—whether that's up a Wasatch climb at sunrise or across the finish line at Leadville. He grew up in Salt Lake City as the oldest of three kids. He earned his Eagle Scout, served an LDS mission in Milan, Italy, earned his Economics degree from the U and MBA from Westminster. He even found time to volunteer at the 2006 Turin Winter Olympics, supporting the U.S. Olympic Team with athlete services and translation. He's been with Optum for 23 years, working his way up from sales to Director of Business Operations, and I think he'd tell you the reason he's stayed so long is because of the people and relationships. He's been married to his wife, Jennilynn, for 17 years - and she keeps him fueled with plenty of baked goods. He is a proud dad of two (one through fertility treatments and one through adoption), and shares his home with Bella, a 5-year-old St. Bernard who probably weighs more than all of his bikes combined. He's been passionate about sports since he was young. He ran track and cross country, once ran a marathon, finishing in 4hrs and 4 min, and swore ‘never again,' and eventually found his true love in cycling. Since then, he's tackled countless endurance events—multiple century rides, six LOTOJAs, Steamboat Springs Gravel, and most recently, the Leadville 100 MTB. Nick is so grateful for the Mi Duole team. Riding with them has pushed him to grow as a cyclist while also creating meaningful friendships that extend beyond the bike.  Around the house, he's known as the guy who fills the garage with bikes, never stops talking about cycling, and occasionally finishes a project or two in between rides. Passionate, disciplined, and just stubborn enough to keep pushing through the hard stuff is what makes him such a strong rider and a great husband and father.

Welcome to the Health Marketing Collective, where strong leadership meets marketing excellence.On today's episode, we're joined once again by Melissa Fors Shackelford, health marketing strategist, accomplished consultant, renowned keynote speaker, and now Amazon's #1 bestselling author with her new book, “Harnessing Purpose: A Marketer's Guide to Inspiring Connection.” Host Sara Payne leads a deep-dive conversation into the essential role of purpose in marketing, exploring how both personal and brand purpose are at the very heart of meaningful work and, crucially, business success.Melissa draws on two decades of shaping brand and growth strategies for healthcare organizations, including Optum, Hazelden Betty Ford, and Cigna's Evernorth, to share why connecting our personal “why” with the organizational mission isn't just aspirational, but also practical, powerful, and profitable. Together, Sara and Melissa unpack the realities of burnout and the so-called “soul-selling” reputation that sometimes haunts the marketing profession, contrasting it with Melissa's own purpose-driven approach. The episode explores how leaders and organizations can avoid performative platitudes, instead cultivating authentic, values-aligned cultures that foster engagement, resilience, creativity, and tangible business outcomes.Whether you're feeling disconnected from the “why” of your day-to-day or are a marketing leader looking to inspire deeper commitment within your team, today's discussion is packed with actionable guidance, real-world examples, and candid advice on harnessing purpose for both individual fulfillment and organizational growth.Key Takeaways:Aligning Personal and Brand Purpose Unlocks Engagement and Performance: Melissa emphasizes that the most effective marketing and the most fulfillment for marketers happens when personal purpose aligns with brand values. Marketers who understand both their own “why” and their organization's mission are more resilient, creative, and motivated, producing authentic campaigns that resonate internally and externally.Purpose-Driven Companies Outperform Competitors: The episode isn't just about feel-good motivation Melissa cites research (from the likes of HBR and Deloitte) that shows 85% of businesses with a clear purpose see sales increase, while 42% without purpose see stagnation or decline. Purpose-driven organizations attract like-minded employees and customers, resulting in higher engagement, loyalty, and performance.Authenticity and Consistency Are Essential to Building Trust: Saying the right things isn't enough; posting values on lanyards or walls without truly living them can actively erode employee and consumer trust. Melissa and Sara discuss why it's critical for leadership to model values and use them as a filter for decisions from hiring to service delivery, especially in high-stakes sectors like healthcare.Purpose as a Decision-Making Filter Empowers Employees: The ultimate goal is for every employee to use company purpose and values as a guide in daily and “in the moment” decisions, especially when leaders aren't around. This means purpose isn't just strategy, it's culture, empowering staff with clarity and confidence, and fueling both psychological safety and creative risk-taking.Marketing Can and Should Be a Force for Good: Melissa challenges marketing's manipulative stereotype by sharing real healthcare examples where marketing ethics and mission-driven approaches protect vulnerable populations and foster positive change. She encourages all marketers to use their role for good, highlighting the growing importance of authenticity in both B2C and B2B environments.To connect with Melissa Fors Shackelford or learn more about her bestselling book, visit harnessingpurpose.com or reach out on...

FHC #186: From rare diseases to rural America, Optum's CEO talks healthcare's future In this special return to Season 10, which focused on transformative technologies in medicine, Fixing Healthcare hosts ... The post FHC #186: Optum CEO on AI, big data & preventing disease appeared first on Fixing Healthcare.

Hannah Ryu is a storyteller, AI Strategist, and the co-founder of Oak Theory, a creative technology studio specializing in UX/UI, web, application design, and development. We explore: Co-founding a creative technology studio, aiming to address the lack of diversity in UX design firms.  Confronting negative self-talk/narratives when building a business The role of perfectionism in Korean culture The exciting utility of AI in creating tailored educational information for children, increasing accessibility to education Use of AI for self-reflection and as a starting point to engage in therapy How to maintain being human through curiosity, accepting that we make mistakes, and unconditional love ========================================== Hannah's full bio: Hannah is a storyteller, AI Strategist, and the co-founder of Oak Theory, a creative technology studio specializing in UX/UI, web, application design, and development. With over a decade of experience across branding, UX/UI, and digital strategy, she partners with organizations navigating transformation, helping them turn complexity into clear, scalable experiences.  As a first-generation Korean American and mother of two, Hannah brings a layered lens to leadership, blending creative instinct, cultural awareness, and operational know-how, especially during times of growth, change, or reinvention. Her expertise has been trusted by industry leaders and universities like Google, Optum, Columbia University, and Vanderbilt University. She's been featured at the Women in Tech Global Conference, on the top 0.5% business podcast The UpFlip Podcast, and in outlets such as Forbes, Success Magazine, and Entrepreneur. The company's websites are oaktheory.co and undertheoak.co. Under the Oak is a media company that seeks to discuss how to be more human. Socials: https://www.instagram.com/oaktheory.co/ https://www.linkedin.com/in/hannahryu/ 

Kevin Sommers is a 2018 graduate of the Harbert College of Business at Auburn University. He currently serves as the Assistant Chief Financial Officer of TriStar Skyline Medical Center, part of HCA Healthcare, in Nashville, TN. He has worked at SCA Health (part of Optum and United Health) in their Financial Operations group, supporting surgery centers and surgical hospitals across multiple states. Before that, Kevin was a member of the finance team at UAB Health System in Birmingham, Alabama.Originally from Huntsville, Alabama, Kevin is a proud alumnus of Auburn University, holding a degree in accounting. He furthered his education at the University of Alabama at Birmingham with a Master of Science in Health Administration and a Master of Business Administration. Outside of work, Kevin enjoys staying active with golf, tennis, and pickleball, and loves to travel and spend time with family and friends. He currently serves on the Young Alumni Council for the Harbert College of Business and is an avid supporter of Auburn athletics.

In this episode of Diabetes Dialogue, recorded live at the 85th Scientific Sessions of the American Diabetes Association (ADA 2025), hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, welcome Jay Shubrook, DO, and Conan Tu, MD, to explore the mission and momentum of the American College of Diabetology. The conversation centers on addressing the national shortage of diabetes specialists. Shubrook, a primary care diabetologist and founding figure in diabetology training, details the evolution of fellowship programs dating back to 2004, with the current infrastructure supporting 11 programs and plans for further expansion. Tu, an internist from New York, shares his personal journey into diabetology, emphasizing the increasing demand for diabetes-focused care in primary settings and the transformative impact of timely, expert-level interventions. The guests outline how the American College of Diabetology is building a standardized, certified workforce through board certification, with an emphasis on team-based care. The College is also actively expanding to include pharmacists, nurse practitioners, and other healthcare professionals in its educational and certification efforts, helping to equip interdisciplinary teams to manage diabetes more effectively. Additional discussion highlights include the importance of continuity of care—particularly during the transition from pediatric to adult diabetes services—the integration of cardiometabolic risk management, and the critical need for scalable models of care. The speakers advocate for diabetologists to serve not only as direct providers but as in-house experts, mentors, and system-level educators capable of elevating care across large networks. Learn more about the American College of Diabetology. Relevant disclosures for Isaacs include Eli Lilly and Company, Novo Nordisk, Sanofi, Abbott Diabetes Care, Dexcom, Medtronic, and others. Relevant disclosures for Bellini include Abbott Diabetes Care, MannKind, Sanofi, and others. Relevant dislcures for Tu include AstraZeneca, Eli Lilly and Company, and Optum. Relevant disclosures for Shubrook include Abbott, AstraZeneca, Bayer, Eli Lilly and Company, and Novo Nordisk.

173: Discover what it's really like to operate at the top. In this eye-opening conversation with Mackenzie Lee, we explore the evolving role of the Chief of Staff, the transformation of the CEO office, and how AI is reshaping leadership. Whether you're an Executive Assistant, rising leader, or startup founder, this episode delivers actionable insights on succession planning, strategic decision-making, and the future of executive operations. Learn how to build a world-class office, improve performance through health checks, and download the top-rated Office of the CEO playbook. --- Mackenzie is the CEO & Founder of Cedar. He helps CEOs and their C-suite teams to let go and do more. He gives leaders the freedom to do things that matter. Mackenzie fights C-suite distractions, busywork and blockers. He helps his clients to hire a Chief of Staff, build the Office of the CEO, and implement operating systems that turn executives into fast and fearless leaders. As a former management consultant, startup founder and Chief of Staff, Mackenzie has almost two decades of experience partnering with C-suite to scale new heights, no matter what challenges they face. Mackenzie has worked with leaders from Fortune 1000 companies, top scaleups, private equity-backed companies, and government organizations, with a particular focus on financial services, technology and healthcare industries. He's advised executives at Google, Palantir, Citi, Optum and the Department of Energy among other top organizations. Mackenzie is a sought-after speaker, researcher, and thought leader on all things related to leadership, Chief of Staff and the Office of the CEO. He is a graduate of the Stanford StartX accelerator, proud Stanford management science & engineering alum and Stanford public policy alum. Mackenzie now lives in New York City. Links Office of the CEO Playbook: https://static1.squarespace.com/static/636a8c999b042104adda3b25/t/67af97f07853b3570690d08e/1739560946882/Cedar+-+The+Office+of+the+CEO+Playbook%2C+1st+Edition.pdf Chief of Staff Playbook https://static1.squarespace.com/static/636a8c999b042104adda3b25/t/67af97e0e4fc9777da84391e/1741362537688/Cedar+-+The+Chief+of+Staff+Playbook%2C+2nd+Edition.pdf Haufe Chief of Staff Zertifizierung https://www.haufe-akademie.de/41675 ---

Over 160 million Americans are served by Optum, yet many still don't fully understand what it actually does—or why it matters.Dr. Patrick Conway, newly appointed CEO of Optum and former head of CMS Innovation Center and Blue Cross NC, joins Steve for a wide-ranging discussion on the state of healthcare delivery, affordability, and the potential of value-based care at a national scale. With experience spanning the frontlines of medicine to top government and corporate leadership, Conway breaks down how Optum aims to improve care while controlling costs—and why he continues to practice as a pediatric hospitalist on weekends.We cover:

Believe it or not, 60% of healthcare payments in the US are tied to value. But it's still surprisingly hard to find examples of health systems that have been doing VBC at scale, successfully, over time. So that's what Advisory Board researchers set out to do. And across 66 conversations with 44 systems, we found four systems with approaches worth emulating. This week, we're unpacking the approach at one of those systems: Advocate Health. Host Abby Burns sits down with Don Calcagno, Chief Population Health Officer and President of Advocate's largest clinically integrated network, Advocate Physician Partners. Don lays out how putting operations at the center has led Advocate to become one of the top-performing systems in Medicare risk models, generate millions of dollars in savings, and, most importantly, improve quality of care. Not to mention, juggle over 100 VBC contracts across 13 accountable care organizations and clinically integrated networks, and carry $1 billion in capitated risk. Links: Read the case study: Inside Advocate Health's VBC approach that saved $136M VBC self-assessment: Find out where your organization stands 2025 Advisory Board Summit- Carlsbad, CA - join us for the full event, and check out our session featuring another VBC case study Registration is live for our VBC Roundtable in October: HOME - How to deliver the next era of VBC Ep. 243: What's now and what's next in value-based care How UNC Health made VBC sustainable in an academic health system Optum Advisory can help you create a VBC strategy for growth and profitability. Connect with an expert. How to succeed in VBC — according to Optum experts VBC success is possible. Here's how. A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

Believe it or not, 60% of healthcare payments in the US are tied to value. But it's still surprisingly hard to find examples of health systems that have been doing VBC at scale, successfully, over time. So that's what Advisory Board researchers set out to do. And across 66 conversations with 44 systems, we found four systems with approaches worth emulating. This week, we're unpacking the approach at one of those systems: Advocate Health. Host Abby Burns sits down with Don Calcagno, Chief Population Health Officer and President of Advocate's largest clinically integrated network, Advocate Physician Partners. Don lays out how putting operations at the center has led Advocate to become one of the top-performing systems in Medicare risk models, generate millions of dollars in savings, and, most importantly, improve quality of care. Not to mention, juggle over 100 VBC contracts across 13 accountable care organizations and clinically integrated networks, and carry $1 billion in capitated risk. Links: Read the case study: Inside Advocate Health's VBC approach that saved $136M VBC self-assessment: Find out where your organization stands 2025 Advisory Board Summit- Carlsbad, CA - join us for the full event, and check out our session featuring another VBC case study Registration is live for our VBC Roundtable in October: HOME - How to deliver the next era of VBC Ep. 243: What's now and what's next in value-based care How UNC Health made VBC sustainable in an academic health system Optum Advisory can help you create a VBC strategy for growth and profitability. Connect with an expert. How to succeed in VBC — according to Optum experts VBC success is possible. Here's how. A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

Tune in for today's industry updates.

Deb Bubb is the former Chief People Officer at Optum and Co-founder of The Institute For Moral Imagination.  This ThoughtCast is an insightful chat about creativity, passion, and purpose. Our guest, Deb Bubb, shared with us how she pivoted into a new chapter of her life, chasing a passion and building something new. Deb also spoke about the fears, uncertainty, and challenges of making a transition and embracing the unknown. The conversation centered on the idea that every life is a creative act. By embracing all of our creativity, we have a way to access all our potential. She shares how she has built creativity and art into her life. This discussion will energize you to dive into your creativity and look for art all around you.  Get in touch Visit us at tignum.com Email us at contact@tignum.com Think clearer. Show up better. Maximize impact.

Welcome to the Health Marketing Collective, where strong leadership meets marketing excellence. In today's episode, host Sara Payne sits down with Mike Cronin, Cofounder and Chief Strategist at Verve, to explore the evolving landscape of creativity in B2B healthcare marketing. Mike, whose impressive résumé includes brand and campaign strategy for UnitedHealth Group, Blue Cross Blue Shield, Optum, and revered consumer brands like Harley-Davidson and Samuel Adams, brings a rare blend of creative vision and strategic rigor to his work. His fundamental belief? That creative work's purpose is to move people, not just fill space. In this conversation, Mike and Sara dive deep into how B2B health brands can move beyond “safe” ideas and unlock emotionally resonant, unforgettable campaigns—even within highly regulated and risk-averse spaces. They discuss why simplicity is a superpower, the importance of strategic “boxes,” and how marketing leaders can create environments where big swings are encouraged, not stifled. Along the way, Mike shares memorable stories from his work (including a campaign that fused Lizzo's “Good as Hell” into healthcare advertising), offers insight into the universal human truths marketers often miss, and outlines what separates teams that produce great creative from those that simply make noise. Thank you for being part of the Health Marketing Collective, where strong leadership meets marketing excellence. The future of health care depends on it. Key Takeaways: Creativity Thrives Within Constraints: Mike challenges the conventional wisdom of “thinking outside the box.” He argues that true creativity is often unlocked not by limitless freedom, but by well-defined strategic constraints. It's within the confines of a focused brief—what Mike calls “the freedom of a tight brief”—that intelligent, emotionally resonant ideas emerge. Rather than aiming for “crazy” or “flashy,” the best creative is smart, intentional, and purpose-driven. Emotion and Human Truth are Universal, Even in B2B: B2B often gravitates toward rational benefits: cost savings, efficiency, or productivity. But, as Mike notes, even financial administrators and clinicians are humans first—they respond to messages that tap into universal emotions and experiences: hope, fear, dignity, and relief from frustration. Brands that connect on this human level, rather than just touting features and benefits, become memorable and meaningful. Strategic Alignment is the Key to Unlocking Great Creative: Teams that produce truly breakthrough work consistently prioritize strategy. When everyone is aligned on the core insight and brief, creativity can flow freely within those parameters. Conversely, weak or vague direction leads to “safe,” generic campaigns. Mike's experience shows that great creative always starts with a shared, sharp strategic foundation. Boldness is Essential for Breaking Through the Noise: Healthcare, especially B2B, often defaults to playing it safe (“everything's blue”)—but in a crowded marketplace, standing out is non-negotiable. Mike advocates for boldness that is grounded in the brand's truth and strategically anchored. The result: unforgettable, not just noisy, marketing. Leadership's Role: Foster Honesty, Empathy, and Trust: Leadership sets the tone for creativity and trust. Mike urges CMOs and marketing leaders to lead with clarity and honesty—eschewing “BS” and toxic positivity for real, truthful dialogue about challenges and opportunities. Teams (and audiences) respond to authenticity; when leaders call things as they are and create space for truth, better work results. Resources and Contact: Want to connect with Mike or learn more about Verve's approach to strategic creativity? Visit

Once called a “unicorn” for her entrepreneurial approach, Vicki Apodaca is a seasoned marketer, entrepreneur, and philanthropist. Vicki has been a founding member of several tech startups (Phalanx, StellarFi, Joust, and Soply), and have also been through two exits (Joust acquired by ZenBusiness, Starship HSA acquired by Optum). Her passion in go-to-market and marketing strategy has led her to now be a Fractional CMO and Advisor across several startups worldwide. A native Burqueña, Vicki co-founded the New Mexico chapter of Techqueria – a Latinx in tech 501(3)(c) nonprofit – and NMClimate – a community for climate and energy-focused entrepreneurs. She lives in a cozy home with her partner and two Pekingese who run their house. Links NM Lottery Program FiatVentures Advisors site Phalanx site Techqueria New Mexic0 site Atomic 66 site Q Station site SpaceValley Foundation site CNM Ingenuity site nDigitize site Vicki on LinkedIn 

Welcome to The Power Lounge. In this episode, we explore a significant shift in healthcare marketing with our guest, Melissa Forrest Shackleford. With over twenty years of experience, Melissa has developed inclusive marketing strategies for organizations such as Optum and the Hazelden Betty Ford Foundation. She joins host Amy Vaughn to discuss how inclusive marketing can challenge stigmas in healthcare.Melissa details her journey and the impact of purpose-driven marketing in breaking down barriers and fostering meaningful consumer connections. The conversation covers the effectiveness of inclusive initiatives, the importance of language and accessibility, and provides practical strategies for obtaining executive support for inclusive marketing efforts. Additionally, Melissa highlights the tools and innovations that are driving change in the industry.This episode offers valuable insights and actionable advice for marketers, healthcare professionals, and anyone committed to making a difference. For further reading, Melissa's book, "Harnessing Purpose: A Marketer's Guide to Inspiring Connection," provides more comprehensive knowledge. Join us in building a more inclusive future.Chapters:00:00 - Introduction02:14 - "Evan North's Transformative Marketing Impact"04:57 - Understanding Consumer Stigma Insights08:18 - "Understanding Health Care Marketing Challenges"11:04 - Fighting Stigma in Lung Cancer Screening13:27 - Progress in Health Care Perception17:26 - Authenticity in Testimonies20:10 - Inclusive Marketing Awareness23:50 - Person-First Language Explained25:15 - Language Nuance and Impact30:56 - Delivery Service Boosted Sales33:29 - Reaching Diverse Audiences Economically37:26 - Champion Accessible UX Today41:44 - Purpose-Driven, Authentic Marketing44:25 - "Values-Driven Consumer Purchases"48:36 - Beyond Performative Inclusivity51:14 - Inclusive Audience Targeting Importance54:02 - Essential Inclusive Marketing Strategies55:25 - OutroQuotes:"Inclusive marketing means truly seeing and understanding each person, unlocking its transformative power."- Amy Vaughan"Shifting from stigma to understanding changes perceptions, saves lives, and forges genuine connections."- Melissa Forrest ShacklefordKey Takeaways:Breaking Stigma Starts with UnderstandingAuthentic Representation MattersAccessibility is Key to InclusivityLanguage as a Powerful ToolLeveraging Technology for PersonalizationInclusivity Equals GrowthConnect with Melissa Forrest Shackleford:LinkedIn: https://www.linkedin.com/in/mfors/Check out Melissa's book: https://a.co/d/5HGTje6Connect with the host Amy Vaughan:LinkedIn: http://linkedin.com/in/amypvaughanPodcast: https://www.togetherindigital.com/podcast/Learn more about Together Digital and consider joining the movement by visiting https://togetherindigital.comSupport the show

It feels like only yesterday that workforce challenges were the biggest problem facing the healthcare industry. While COVID-19-related staffing shortages may have declined, an inefficient workforce can still threaten health system operations and finances. Often, systems turn to staffing ratios or benchmarks to determine whether they need more cuts or more hires. However, systems need more than staffing ratios to make sure they have the right headcount and the right expertise in place to safely and effectively care for patients. The question is: if workforce benchmarks aren't enough, then what is? To answer that question, host Rachel (Rae) Woods invites Advisory Board nursing expert Ali Knight to unpack the state of the workforce five years after the peak of COVID-19. Later, Rae brings on Optum Advisory workforce management experts Sherilynn Quist and Anne Schmidt to break down their work in the field, addressing what they call the “blocking and tackling” of workforce efficiency within a hospital. Links: Optum Advisory: Healthcare consulting services [Webinar, May 18] Broaden your definition of the nursing care team Insights from Advisory Board's 2024 workforce benchmarks [Roundtable, Aug. 18-19] How to thrive in an evolving nursing landscape Ep. 205: Live from ViVE 2024: Four leaders on how technology is redefining clinical work Ep. 207: Nurses Week 2024: Build care teams, not assembly lines 2025 Advisory Board Summit - Carlsbad, CA Advisory Board Fellowship Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent. A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

It feels like only yesterday that workforce challenges were the biggest problem facing the healthcare industry. While COVID-19-related staffing shortages may have declined, an inefficient workforce can still threaten health system operations and finances. Often, systems turn to staffing ratios or benchmarks to determine whether they need more cuts or more hires. However, systems need more than staffing ratios to make sure they have the right headcount and the right expertise in place to safely and effectively care for patients. The question is: if workforce benchmarks aren't enough, then what is? To answer that question, host Rachel (Rae) Woods invites Advisory Board nursing expert Ali Knight to unpack the state of the workforce five years after the peak of COVID-19. Later, Rae brings on Optum Advisory workforce management experts Sherilynn Quist and Anne Schmidt to break down their work in the field, addressing what they call the “blocking and tackling” of workforce efficiency within a hospital. Links: Optum Advisory: Healthcare consulting services [Webinar, May 18] Broaden your definition of the nursing care team Insights from Advisory Board's 2024 workforce benchmarks [Roundtable, Aug. 18-19] How to thrive in an evolving nursing landscape Ep. 205: Live from ViVE 2024: Four leaders on how technology is redefining clinical work Ep. 207: Nurses Week 2024: Build care teams, not assembly lines 2025 Advisory Board Summit - Carlsbad, CA Advisory Board Fellowship Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent. A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

In this episode, Dr. Ken Cohen, Executive Director of Translational Research at Optum Health, discusses the impact of value-based care models on patient outcomes. He shares key findings from his recent research, including how Medicare Advantage patients in value-based arrangements receive superior care and how these benefits extend to traditional Medicare patients.

There is a lot happening in federal policy that may affect healthcare payment transformation and care delivery. But we've said it before: healthcare leaders can't afford to focus on fighting near-term fires at the expense of driving long-term success and sustainability. Amidst the uncertainty, it's more important than ever to push forward conversations about how we can structurally evolve our systems to align incentives to patient health. So, in this episode, we're talking about value-based care. Host Abby Burns invites Advisory Board expert Clare Wirth and Optum Advisory expert Erik Johnson to unpack the state of VBC in early 2025, and where they see it going next. They debate whether bundles can truly be considered “value-based care,” how specialty care will fit into the future VBC landscape, and which payer lines of business they have their eyes on. Links: VBC in 2025: What's now and what's next Inside Advocate Health's VBC approach that saved $136M How UNC Health made VBC sustainable in an academic health system The obstacles between health systems and VBC success Ep. 201: Value series: What does health system VBC adoption actually look like? Ep. 231: Big deal, little deal, or no deal? A 2024 health policy retrospective Value-based care landing page Optum Advisory can help you design a VBC strategy that drives sustainable growth and profitability. Get in touch Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent. A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

There is a lot happening in federal policy that may affect healthcare payment transformation and care delivery. But we've said it before: healthcare leaders can't afford to focus on fighting near-term fires at the expense of driving long-term success and sustainability. Amidst the uncertainty, it's more important than ever to push forward conversations about how we can structurally evolve our systems to align incentives to patient health. So, in this episode, we're talking about value-based care. Host Abby Burns invites Advisory Board expert Clare Wirth and Optum Advisory expert Erik Johnson to unpack the state of VBC in early 2025, and where they see it going next. They debate whether bundles can truly be considered “value-based care,” how specialty care will fit into the future VBC landscape, and which payer lines of business they have their eyes on. Links: VBC in 2025: What's now and what's next Inside Advocate Health's VBC approach that saved $136M How UNC Health made VBC sustainable in an academic health system The obstacles between health systems and VBC success Ep. 201: Value series: What does health system VBC adoption actually look like? Ep. 231: Big deal, little deal, or no deal? A 2024 health policy retrospective Value-based care landing page Enjoying this episode? Discover how Optum Advisory experts can help you design a VBC strategy to drive sustainable growth and profitability for your organization. Connect with one of our experts today. Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent. A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

In this episode, Dr. Ken Cohen, Executive Director of Translational Research at Optum Health, discusses the impact of value-based care models on patient outcomes. He shares key findings from his recent research, including how Medicare Advantage patients in value-based arrangements receive superior care and how these benefits extend to traditional Medicare patients.

Partnerships between health systems and life sciences play a critical role in giving patients access to the best data, therapies, and technologies available in the market. However, these partnerships can be less fulfilling if both sides don't align on purpose and expectations. This week, host Rachel (Rae) Woods invites Advisory Board expert Fanta Cherif to break down the current state of health system and life sciences partnerships, share the spectrum of collaboration options, and the strategic middle ground that is often overlooked, but can serve as a lifeline in today's challenging economic landscape. Let us know what you think about today's discussion, or share your ideas for future episode topics by leaving us a voice message or emailing us. Links: Ep. 151: Making vendor-provider partnerships work Ep. 183: John Muir Health and Optum reflect on what makes their partnership work How to bridge the communication gap in vendor-provider partnerships Metrics that matter: How different stakeholders define value in healthcare Join Advisory Board experts for these upcoming philanthropy webinars: March 20, 2025 (1-2 p.m. ET/10-11 a.m. PT): What the future of health system growth means for philanthropy leaders Register here: What the future of health system growth means for philanthropy leaders April 1, 2025 (1-2 p.m. ET/10-11 a.m. PT): How market data can transform your philanthropy strategy Register here: Using market data to inform your philanthropy strategy A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

Partnerships between health systems and life sciences play a critical role in giving patients access to the best data, therapies, and technologies available in the market. However, these partnerships can be less fulfilling if both sides don't align on purpose and expectations. This week, host Rachel (Rae) Woods invites Advisory Board expert Fanta Cherif to break down the current state of health system and life sciences partnerships, share the spectrum of collaboration options, and the strategic middle ground that is often overlooked, but can serve as a lifeline in today's challenging economic landscape. Let us know what you think about today's discussion, or share your ideas for future episode topics by leaving us a voice message or emailing us. Links: Ep. 151: Making vendor-provider partnerships work Ep. 183: John Muir Health and Optum reflect on what makes their partnership work How to bridge the communication gap in vendor-provider partnerships Metrics that matter: How different stakeholders define value in healthcare Join Advisory Board experts for these upcoming philanthropy webinars: March 20, 2025 (1-2 p.m. ET/10-11 a.m. PT): What the future of health system growth means for philanthropy leaders Register here: What the future of health system growth means for philanthropy leaders April 1, 2025 (1-2 p.m. ET/10-11 a.m. PT): How market data can transform your philanthropy strategy Register here: Using market data to inform your philanthropy strategy A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

Dr. Harlan Levine began his career practicing internal medicine but soon moved into business leadership roles at national healthcare organizations to help improve the dysfunction with payer-provider relationships that he experienced firsthand as a physician.At United Health Group, Dr. Levine joined as clinical lead of the team that launched Optum, where he subsequently served as chief medical officer for more than six years. He also led the health management practice at Towers Watson and served as executive vice president of comprehensive health solutions at WellPoint, among other roles.In 2013, Dr. Levine joined City of Hope, one of the country's largest and most advanced cancer research and treatment organizations. City of Hope's uniquely integrated model spans cancer care, research and development, academics and training, and a broad philanthropy program that powers its work. City of Hope's growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas.In addition to currently serving as president of health innovation and policy at City of Hope, Dr. Levine is also chair of the board of AccessHope. A spinout from City of Hope, AccessHope partners with the nation's most prestigious cancer research centers to help make leading-edge cancer care available to all, regardless of geographical location.Dr. Levine joined Keith Figlioli for the second episode of a Healthcare is Hard series exploring opportunities in oncology. Some of the topics they discussed include:Community practice vs. academic medical centers. Delivering personalized care and giving patients access to cutting-edge treatment is equally important, yet historically difficult to balance. In the first episode of this series, Dr. Stephen Schleicher from Tennessee Oncology shared how one of the nation's most successful community oncology practices is tackling the challenge. In this episode, Dr. Levine discussed City of Hope's model of putting academic research at the center and connecting it with community practices. He described how City of Hope is changing the direction of cancer care – not just delivering it – by giving patients faster access to emerging science.Defining value in oncology. Dr. Levine calls himself an outlier when it comes to value-based care in oncology because he thinks the industry missed a critical first step – defining what the term means. In most circumstances, discussions around value are centered around reducing cost. But Dr. Levine points out that a cancer patient defines value very differently. They define it as survival. They think about whether or not they returned to normal functionality in normal life, and what their experience was through the entire treatment process. He says the industry needs to recognize and customize models for these unique aspects of cancer care before the term VBC should be used in oncology.AI in oncology. Dr. Levine shared his outlook for the many ways artificial intelligence will change oncology – from drug discovery to care delivery. He believes AI will completely disrupt the approach to cancer care and that the revolution will happen quickly – not in seven to 10 years, but in three to five. He talked about the ways he sees AI changing how doctors deliver care, and why he's even more optimistic about its ability to accelerate research.To hear Dr. Levine and Keith discuss these topics and more, listen to this episode of Healthcare is Hard: A Podcast for Insiders.

Host: David Rosenblum, MD Guest: Phillip Kim, MD Date: January 24, 2025 Time: 6:30 AM Episode Summary: In this episode of the PainExam Podcast, Dr. David Rosenblum engages with Dr. Phillip Kim to discuss the Federation Pain Care Access, a newly formed organization advocating for improved access to interventional pain treatments. The episode delves into the challenges posed by restrictive insurance coverage policies and the collaborative efforts needed to address these issues effectively. Key Discussion Points: -Introduction to Federation Pain Care Access: A new entity focused on advocating for emergent and standard care in interventional pain treatments, aiming to enhance access through advocacy and legislative solutions. - Impact of Restrictive Policies: Dr. Kim highlights how insurance carriers like Evicor, AIM, and Optum impose restrictive coverage policies that harm patients and practitioners, particularly amid the ongoing opioid epidemic.AIM, Optum and Evicore are not insurance carriers. these are separate entities which oversee utilization management and prior auth requests for insurance carriers (HMO, TPA's etc) e g. BCBS plans, UHS etc. Prior Authorization Challenges: Discussion on the AMA 2022 Prior Authorization Physician Survey, which indicates significant negative impacts on patient care due to prior authorization processes. - Case Studies: Dr. Kim shares specific cases where patients faced harm due to denied claims, including issues related to medical cannabis and necessary medical equipment.   - Collaboration with Medical Societies: The Federation works alongside various pain societies and stakeholders to address common concerns and push for better coverage policies. - Future Goals Plans for meetings with CMS and Medicare Administrative Contractors (MACs) regarding specific treatments like SI joint radiofrequency ablation, aiming to improve coverage and access.   Fundraising and Outreach: The Federation seeks to grow its membership and funding through outreach to allied health professionals and patient care groups while launching a media campaign to raise awareness of patient struggles  Legal and Advocacy Efforts: Emphasis on the need for legal considerations in advocacy efforts and the importance of public support in achieving the Federation's goals. - The No Pain Act: Discussion on recent legislation aimed at expanding access to non-opioid treatments and alternatives for chronic pain management. Guest Bio: Phillip Kim, MD is a leading advocate for pain care access and a founding member of the Federation Pain Care Access. He brings extensive experience in managing chronic pain patients and navigating healthcare policies. Resources  Federation Pain Care Access Website:  https://www.painfed.org # board Listeners are encouraged to support the Federation Pain Care Access by visiting their website to learn more about their initiatives and consider contributing to help advance their mission. Join Dr. Rosenblum and Dr. Kim in this vital conversation about the ongoing efforts to improve pain care access and the importance of collaboration in overcoming the challenges faced by patients and healthcare providers.   Long island based anesthesiologist, David Rosenblum, MD, is one of the first interventional pain physicians in the country to integrate ultrasound guidance into his pain practice. Since 2007, he has been an international leader in the treatment of chronic pain. He has helped countless of patients suffering from back, neck, knee, shoulder, hip joint pain and has been at the forefront of regenerative pain medicine, minimally invasive pain therapies and medical education.  Patients can schedule a consultation by going to  www.AABPpain.com or calling: Brooklyn Office 718 436 7246 Garden City Office 516 482 7246

Michael welcomes Sandy Rolfe, Chair of the WEDI Genomics Workgroup and Clinical Lead for the InterQual Molecular Diagnostics and Durable Medical Equipment at Optum. The two discuss the ever evolving state of Genomics research, data privacy and security, and how data interoperability and standards can aid in care and patient satisfaction. WEDI members are invited to attend a special Genomics workgroup event, Exploring Genomic Data Exchange: A Deep Dive into FHIR Integration and Interoperability, Feb 27 on Zoom, exclusive for WEDI members. Visit www.wedi.org to sign up.

Host: David Rosenblum, MD Guest: Phillip Kim, MD Date: January 24, 2025 Time: 6:30 AM Episode Summary: In this episode of the PainExam Podcast, Dr. David Rosenblum engages with Dr. Phillip Kim to discuss the Federation Pain Care Access, a newly formed organization advocating for improved access to interventional pain treatments. The episode delves into the challenges posed by restrictive insurance coverage policies and the collaborative efforts needed to address these issues effectively. Key Discussion Points: -Introduction to Federation Pain Care Access: A new entity focused on advocating for emergent and standard care in interventional pain treatments, aiming to enhance access through advocacy and legislative solutions. - Impact of Restrictive Policies: Dr. Kim highlights how insurance carriers like Evicor, AIM, and Optum impose restrictive coverage policies that harm patients and practitioners, particularly amid the ongoing opioid epidemic. AIM, Optum and Evicore are not insurance carriers. these are separate entities which oversee utilization management and prior auth requests for insurance carriers (HMO, TPA's etc) e g. BCBS plans, UHS etc. Prior Authorization Challenges: Discussion on the AMA 2022 Prior Authorization Physician Survey, which indicates significant negative impacts on patient care due to prior authorization processes. - Case Studies: Dr. Kim shares specific cases where patients faced harm due to denied claims, including issues related to medical cannabis and necessary medical equipment.   - Collaboration with Medical Societies: The Federation works alongside various pain societies and stakeholders to address common concerns and push for better coverage policies. - Future Goals Plans for meetings with CMS and Medicare Administrative Contractors (MACs) regarding specific treatments like SI joint radiofrequency ablation, aiming to improve coverage and access.   Fundraising and Outreach: The Federation seeks to grow its membership and funding through outreach to allied health professionals and patient care groups while launching a media campaign to raise awareness of patient struggles  Legal and Advocacy Efforts: Emphasis on the need for legal considerations in advocacy efforts and the importance of public support in achieving the Federation's goals. - The No Pain Act: Discussion on recent legislation aimed at expanding access to non-opioid treatments and alternatives for chronic pain management. Guest Bio: Phillip Kim, MD is a leading advocate for pain care access and a founding member of the Federation Pain Care Access. He brings extensive experience in managing chronic pain patients and navigating healthcare policies. Resources  Federation Pain Care Access Website:  https://www.painfed.org # board Listeners are encouraged to support the Federation Pain Care Access by visiting their website to learn more about their initiatives and consider contributing to help advance their mission. Join Dr. Rosenblum and Dr. Kim in this vital conversation about the ongoing efforts to improve pain care access and the importance of collaboration in overcoming the challenges faced by patients and healthcare providers.   Long island based anesthesiologist, David Rosenblum, MD, is one of the first interventional pain physicians in the country to integrate ultrasound guidance into his pain practice. Since 2007, he has been an international leader in the treatment of chronic pain. He has helped countless of patients suffering from back, neck, knee, shoulder, hip joint pain and has been at the forefront of regenerative pain medicine, minimally invasive pain therapies and medical education.  Patients can schedule a consultation by going to  www.AABPpain.com or calling: Brooklyn Office 718 436 7246 Garden City Office 516 482 7246

Host: David Rosenblum, MD Guest: Phillip Kim, MD Date: January 24, 2025 Time: 6:30 AM Episode Summary: In this episode of the PainExam Podcast, Dr. David Rosenblum engages with Dr. Phillip Kim to discuss the Federation Pain Care Access, a newly formed organization advocating for improved access to interventional pain treatments. The episode delves into the challenges posed by restrictive insurance coverage policies and the collaborative efforts needed to address these issues effectively. Key Discussion Points: -Introduction to Federation Pain Care Access: A new entity focused on advocating for emergent and standard care in interventional pain treatments, aiming to enhance access through advocacy and legislative solutions. - Impact of Restrictive Policies: Dr. Kim highlights how insurance carriers like Evicor, AIM, and Optum impose restrictive coverage policies that harm patients and practitioners, particularly amid the ongoing opioid epidemic. AIM, Optum and Evicore are not insurance carriers. these are separate entities which oversee utilization management and prior auth requests for insurance carriers (HMO, TPA's etc) e g. BCBS plans, UHS etc. Prior Authorization Challenges: Discussion on the AMA 2022 Prior Authorization Physician Survey, which indicates significant negative impacts on patient care due to prior authorization processes. - Case Studies: Dr. Kim shares specific cases where patients faced harm due to denied claims, including issues related to medical cannabis and necessary medical equipment.   - Collaboration with Medical Societies: The Federation works alongside various pain societies and stakeholders to address common concerns and push for better coverage policies. - Future Goals Plans for meetings with CMS and Medicare Administrative Contractors (MACs) regarding specific treatments like SI joint radiofrequency ablation, aiming to improve coverage and access.   Fundraising and Outreach: The Federation seeks to grow its membership and funding through outreach to allied health professionals and patient care groups while launching a media campaign to raise awareness of patient struggles  Legal and Advocacy Efforts: Emphasis on the need for legal considerations in advocacy efforts and the importance of public support in achieving the Federation's goals. - The No Pain Act: Discussion on recent legislation aimed at expanding access to non-opioid treatments and alternatives for chronic pain management. Guest Bio: Phillip Kim, MD is a leading advocate for pain care access and a founding member of the Federation Pain Care Access. He brings extensive experience in managing chronic pain patients and navigating healthcare policies. Resources  Federation Pain Care Access Website:  https://www.painfed.org # board Listeners are encouraged to support the Federation Pain Care Access by visiting their website to learn more about their initiatives and consider contributing to help advance their mission. Join Dr. Rosenblum and Dr. Kim in this vital conversation about the ongoing efforts to improve pain care access and the importance of collaboration in overcoming the challenges faced by patients and healthcare providers.   Long island based anesthesiologist, David Rosenblum, MD, is one of the first interventional pain physicians in the country to integrate ultrasound guidance into his pain practice. Since 2007, he has been an international leader in the treatment of chronic pain. He has helped countless of patients suffering from back, neck, knee, shoulder, hip joint pain and has been at the forefront of regenerative pain medicine, minimally invasive pain therapies and medical education.  Patients can schedule a consultation by going to  www.AABPpain.com or calling: Brooklyn Office 718 436 7246 Garden City Office 516 482 7246

In this conversation, Dr. David Carmouche discusses the critical transition from fee-for-service to value-based care in the healthcare industry, emphasizing the role of AI in enhancing primary care and improving patient outcomes. He highlights the financial pressures on health systems and the importance of aligning incentives to achieve sustainability. The discussion also covers the innovative solutions offered by Lumeris and the transformative potential of AI in automating care processes and improving patient engagement. Finally, Dr. Carmouche addresses the need for regulatory guardrails as AI becomes more integrated into healthcare delivery.In this episode , they discuss:The shift from fee-for-service to value-based care is essential for financial sustainability.AI is poised to transform primary care delivery and patient engagement.Healthcare costs have been deemed unsustainable for decades, necessitating change.Aligning incentives is crucial for improving patient outcomes in healthcare.Lumeris has a decade-long history of partnering with health systems for value-based care.AI can automate and standardize care processes, enhancing efficiency.Data availability and interoperability are key to successful value-based care models.Generative AI can proactively engage patients and improve care delivery.Training clinicians to effectively use AI is vital for its successful integration.Regulatory guardrails will be necessary as AI becomes more prevalent in healthcare.A little about Dr David Carmouche: David Carmouche, MD, is the Executive Vice President & Chief Clinical Transformation Officer at Lumeris. Dr. Carmouche is a visionary leader in transformational healthcare delivery, with a unique blend of provider, payer, retail, and integrated delivery network leadership experience.Prior to joining Lumeris, Dr. Carmouche served as Walmart's Senior Vice President of Healthcare Delivery, where he led the fleet of Walmart Health centers, Walmart Health Virtual Care, a value-based care partnership with Optum, and Walmart's work to address Social Determinants of Health. Dr. Carmouche has also held significant leadership roles with Ochsner Health, the largest nonprofit academic healthcare system in the Gulf South, and Blue Cross Blue Shield of Louisiana, where he introduced the company's first value-based care contracts. Earlier in his career, he built and led a multidisciplinary internal medicine and preventive cardiology practice.Dr. Carmouche attended Tulane University and LSU Medical School in New Orleans. Board-certified in Internal Medicine, he completed his residency at the University of Alabama at Birmingham, where he later served as Chief Resident. He serves as President of the Board of the Consortium for Southeastern Healthcare Quality and on the advisory board at Stellar Health. He has served on the board of the National Association of Accountable Care Organizations.

AP correspondent Haya Panjwani reports on a Wisconsin couple suing Walgreens and Optum Rx.

Back in December, we discussed why leaders should re-envision their approach to digital change management. But to truly implement digital change, health systems must understand their organization's success (or failure) to date. However, assessing digital progress is not a simple task. While models exist that measure digital maturity in other industries, there is a serious lack of tools to measure progress in the healthcare field—which is why we made our own. This week, host Rachel (Rae) Woods invites John League, Advisory Board digital health expert, and K. R. Prabha, Optum's Vice President of Strategy, Growth and Innovation to define what digital maturity for health systems looks like and unpack why so many organizations are stalled at merely “being” digital. Together, they introduce a new tool they've designed to help health systems assess their own digital maturity. For an on-the-ground perspective, Rae invites Dr. David Ingham, Vice President and Chief Information Officer of Allina Health, to discuss how Allina Health leveraged this tool to assess their progress and prioritize next steps on their digital journey. Links: Understand the digital maturity of your health system Ep. 233: Your digital strategy needs more than “change management” Connect with Optum Advisory to design your digital transformation strategy Allina Health Care & Medical Services In MN & Western WI Get in touch with us [Webinar, 2/19] Imaging market trends in 2025 Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent. A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

Back in December, we discussed why leaders should re-envision their approach to digital change management. But to truly implement digital change, health systems must understand their organization's success (or failure) to date. However, assessing digital progress is not a simple task. While models exist that measure digital maturity in other industries, there is a serious lack of tools to measure progress in the healthcare field—which is why we made our own. This week, host Rachel (Rae) Woods invites John League, Advisory Board digital health expert, and K. R. Prabha, Optum's Vice President of Strategy, Growth and Innovation to define what digital maturity for health systems looks like and unpack why so many organizations are stalled at merely “being” digital. Together, they introduce a new tool they've designed to help health systems assess their own digital maturity. For an on-the-ground perspective, Rae invites Dr. David Ingham, Vice President and Chief Information Officer of Allina Health, to discuss how Allina Health leveraged this tool to assess their progress and prioritize next steps on their digital journey. Links: Understand the digital maturity of your health system Ep. 233: Your digital strategy needs more than “change management” Optum Advisory: Healthcare consulting services Allina Health Care & Medical Services In MN & Western WI Get in touch with us [Webinar, 2/19] Imaging market trends in 2025 Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent. A transcript of this episode as well as more information and resources can be found on RadioAdvisory.advisory.com.

In this episode, Scott Becker and Jakob Emerson, Associate News Director at Becker's Healthcare, explore UnitedHealth Group's 2024 earnings report, the challenges faced in Medicare Advantage, and the strategic shifts at Optum, including its move away from urgent care.

David Toung and Matt Montefusco break down UnitedHealth's (UNH) earnings. David says rising medical and prescription costs are pressuring EPS and revenue. However, he thinks the company is building a long-term growth model. Matt highlights elective procedures rising and the potential headwinds of the Trump administration cutting medical spending. He says they should focus more on their Optum segment than the insurance unit. ======== Schwab Network ======== Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185 Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7 Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch Watch on Vizio - https://www.vizio.com/en/watchfreeplus-explore Watch on DistroTV - https://www.distro.tv/live/schwab-network/ Follow us on X – https://twitter.com/schwabnetwork Follow us on Facebook – https://www.facebook.com/schwabnetwork Follow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

When it comes to leadership, emotional intelligence often gets overlooked. For years, the American work culture has emphasized suppressing emotions in the workplace. But times are changing.Today, emotional intelligence is as crucial as any leadership skill–if not the most essential. Our guest is here to show us why it matters and how to manage our emotions effectively.Meet Roberta Fernandez. Roberta is a professional development consultant specializing in emotional intelligence and organizational cultural change. She holds a Master Practitioner certification in NLP and is a Board-certified Hypnotherapist, making her uniquely skilled in understanding human behavior. Roberta's past clients form a diverse portfolio, including Kemps, Sam's Club, Target, Optum, Pentair, governments, academic institutions, and private small businesses.In this episode, Roberta and I explore the transformative power of emotional intelligence in the workplace. Roberta shares how emotions influence behavior and introduces practical tools for managing team dynamics effectively.With practical tips on staying calm in heated situations, navigating tough conversations, and recognizing workplace emotions, this episode is packed with insights to improve your leadership and collaboration skills.Join the conversation now!Get FREE mini-episode guides with the big idea from the week's episode delivered to your inbox when you subscribe to my weekly email.Conversation Topics(00:00) Introduction(01:56) What is emotional intelligence?(04:06) Understanding and addressing your emotions(07:28) Why emotional awareness is critical for managers(11:32) The FARE framework (Focus, Associate, Repeat, and Expect) explained(16:45) Tips for navigating the emotions that come with change(19:21) How to manage emotions during heated conversations(25:19) Why do people act based on their beliefs(30:19) A great manager Roberta has worked for(31:16) Keep up with Roberta(31:22) [Extended Episode Only] How to proactively prevent a conversation from getting emotional(34:28) [Extended Episode Only] Using the Frame Tool for taking emotions out of team problem-solvingAdditional Resources:- Get the extended episode by Joining The Modern Manager Podcast+ Community for just $15 per month- Read the full transcript here- Follow me on Instagram here - Visit my website for more here- Upskill your team here- Subscribe to my YouTube Channel hereKeep up with Roberta Fernandez- Follow Roberta on LinkedIn and Instagram- Visit her website for more information hereFREE Emotional Intelligence Assessment and the Frame ToolRoberta is providing members of Podcast+ with access to her emotional intelligence assessment as well as “the frame” tool, which she explains in the extended episode.To get this guest bonus and many other member benefits, become a member of The Modern Manager Podcast+ Community.---------------------The Modern Manager is a leadership podcast for rockstar managers who want to create a working environment where people thrive, and great work gets done.Follow The Modern Manager on your favorite podcast platform so you won't miss an episode!

In this conversation, Yaw Fellin, Vice President of Product and Solutions for Clinical Effectiveness at Wolters Kluwer Health, discusses the integration of AI in healthcare, focusing on clinical decision support, partnerships, and the importance of responsible AI practices. He shares insights from the HLTH 2024 conference, highlighting the enthusiasm for AI technologies and the need for improvements in provider workflows. The discussion also covers significant partnerships aimed at enhancing clinical care and the evolving role of AI in reducing provider burden.In this episode they discuss:The focus is on helping clinicians make the best decisions.Small time increments in workflows can lead to significant improvements.There's genuine enthusiasm for AI's tangible benefits in healthcare.Responsible approaches to AI are crucial to eliminate bias.Partnerships are essential for advancing healthcare technology.AI can significantly reduce provider burnout and improve workflows.The integration of AI in clinical settings is a powerful opportunity.Investing in responsible AI practices is a priority for healthcare organizations.Collaboration across care teams can enhance patient care.The future of AI in healthcare is promising but requires careful navigation.A little bit about Yaw : Yaw Fellin brings more than 20 years of experience as a healthcare executive, with proven results leading cross-functional teams, generating value and revenue growth.Prior to joining Wolters Kluwer Health, Yaw spent 3 years at Optum, a global healthcare IT company. Before that, Yaw spent over 15 years at the Advisory Board, a leading healthcare research, consulting and technology firm, where he led multiple high growth SaaS business lines. He received a BS in Healthcare Administration from Penn State University.

Welcome solo and group practice owners! We are Liath Dalton and Evan Dumas, your co-hosts of Group Practice Tech. In our latest episode, we explore the impact of the recent rate cuts for Headway and Alma clinicians. We discuss: The common anxieties around corporate/VC owned telehealth companies The incentives these companies use to lure clinicians The cracks starting to appear in these companies How the rate cuts will impact clinicians How the rate cuts will impact group practices and solo practices Listen here:  https://personcenteredtech.com/group/podcast/ For more, visit our website. Resources Clear Health Costs article: UnitedHealth-Optum pay cut makes clinicians reassess value of tech mental health platforms Clear Health Costs article: 2 digital mental health platforms cut pay rates for therapists with UnitedHealth's Optum, stirring anger PCT Resources Group Practice Care Premium weekly (live & recorded) direct support & consultation service, Group Practice Office Hours -- including monthly session with therapist attorney Eric Ström, JD PhD LMHC + assignable staff HIPAA Security Awareness: Bring Your Own Device training + access to Device Security Center with step-by-step device-specific tutorials & registration forms for securing and documenting all personally owned & practice-provided devices (for *all* team members at no per-person cost) + assignable staff HIPAA Security Awareness: Remote Workspaces training for all team members + access to Remote Workspace Center with step-by-step tutorials & registration forms for securing and documenting Remote Workspaces (for *all* team members at no per-person cost) + more HIPAA Risk Analysis & Risk Mitigation Planning service for mental health group practices -- care for your practice using our supportive, shame-free risk analysis and mitigation planning service. You'll have your Risk Analysis done within 2 hours, performed by a PCT consultant, using a tool built specifically for mental health group practice, and a mitigation checklist to help you reduce your risks.

President-elect Donald Trump nominates Robert F. Kennedy Jr. as the next Secretary of the Department of Health and Human Services. And the Biden Administration sues to halt Optum's multibillion dollar acquisition of home health provider Amedisys on antitrust grounds. We get those stories—and more—coming up on today's episode of the Gist Healthcare podcast. Hosted on Acast. See acast.com/privacy for more information.

In this episode, host Sandy Vance talks with Bill Miller, CEO of WellSky, about the evolving role of analytics in healthcare and its impact on patient care. Bill emphasizes that the healthcare industry must invest in AI solutions to tackle pressing challenges, such as the home-based care staffing crisis, reducing clinician "pajama time," ensuring smoother transitions from hospital to post-acute care and streamlining workflows within existing electronic health record systems. These advancements will enable clinicians to focus on what truly matters—providing human-centered care. Bill also discusses WellSky's collaboration with Google to develop AI tools designed to support, not replace, clinicians.In this episode, they talk about:What WellSky does for the healthcare industry, specifically in direct careHow WellSky helps clinicians deliver optimal patient careWellSky's balanced approach to AI in healthcareThe importance of proactive versus reactive strategiesSupporting clients in and out of hospital settingsAccelerating the referral process with AI solutionsThe rationale behind WellSky's partnership with GoogleThe future of WellSky and AI in healthcareA Little About Bill:Bill Miller is the CEO of WellSky and a recognized leader in the healthcare industry. He has a rich background including more than 25 years of groundbreaking growth strategies and technological innovation in the healthcare marketplace and a proven track record of launching and leading highly successful healthcare IT companies. Under Bill's leadership, WellSky has become one of America's largest and most innovative healthcare technology companies, serving more than 20,000 clients across acute, post-acute, and community care. He has overseen the strategic acquisition of more than 14 companies to the WellSky portfolio, helped establish the WellSky Foundation, and guided the company into new marketplaces with innovative technology and services shaping the industry. Before joining WellSky in 2017, Bill served as the CEO of OptumInsight, a division of Optum, which is the health services platform of UnitedHealth Group. Under Bill's direction, OptumInsight experienced unprecedented revenue growth, expanded margins, and claimed a transformative position in the health services market. He led the evolution of Optum into the leader in healthcare analytics and launched several tech-enabled business platforms. Before OptumInsight, Bill served as senior vice president of technologies at Cerner Corporation, where he had global responsibility for the company's managed services, outsourcing, and technology services business units. Bill currently sits on the board of directors for Lyric and Lifestance, both in the healthcare sector and the WellSky Foundation. A graduate of the University of Kansas, Bill earned his bachelor's degree in economics and a master's degree in urban planning and public policy. He enjoys spending time with his three children Ellie, 24, Belle, 21, and Matthew, 20.

Emotional intelligence isn't just a personal skill; it's a powerful asset that shapes entire cultures, fuels resilience, and boosts productivity across teams. In this episode, we'll uncover the secrets that make these organizations thrive. Whether you're a leader, team member, or just passionate about creating positive workplace environments, there's something here for you.  With me to discuss this topic is Roberta Fernandez, a pioneering expert in facilitating organizational change and fostering positive, cooperative cultures. Roberta's work focuses on helping organizations elevate their internal dynamics, addressing issues like customer service, employee engagement, retention, and communication. With her extensive background in cognitive transformation, emotional intelligence, and systems thinking, she empowers leaders to create environments where collaboration thrives. Roberta's past clients form a diverse portfolio, including Kemps, Sam's Club, Target, Optum, Pentair, governments, academic institutions, and private small businesses.

The Current State of Podcasting: A Comprehensive GuideIn the latest episode of our podcast, we had the pleasure of hosting Jeff Umbro, the CEO of Podglomerate. Jeff shared his extensive knowledge about the podcasting industry, offering valuable insights into its growth, best practices for independent podcasters, and effective monetization strategies. This blog post will break down the key points discussed in the episode, providing actionable advice and thorough explanations to help you navigate the podcasting landscape.Jeff begins by highlighting the impressive growth of podcasting over the past 16 years. According to the Edison Infinite Dial Report, approximately 132 million people in the U.S. listen to podcasts regularly, averaging about seven shows each month. This growth has been further accelerated by the pandemic, which increased streaming audio consumption. Podglomerate, founded in 2017, is a podcast services company that focuses on producing, marketing, and monetizing podcasts. They work with a diverse range of clients, from large corporations like Netflix and PBS to small businesses and individual creators. Jeff emphasizes that their goal is to help podcasters create high-quality content and effectively reach their target audience.Jeff also discusses the recent consolidation in the podcasting industry, with major players like Spotify, SiriusXM, and Apple acquiring smaller companies. This consolidation has led to a shift in the types of shows being produced, with a growing focus on ad sales and listener engagement. Despite these changes, advertising on podcasts remains highly effective. Jeff notes that podcast ads often outperform other digital mediums, attracting more brands to the space. He emphasizes the importance of creating quality content that resonates with listeners and advises podcasters to focus on engagement metrics such as social media mentions, listener feedback, and overall consumption patterns. For those with limited budgets, Jeff recommends leveraging owned properties like websites, newsletters, and social media to promote their shows and suggests cross-promotion with similar shows as a more effective strategy for audience growth.About Jeff Umbro:Jeff Umbro is the founder and CEO of The Podglomerate, the award-winning company which produces, distributes, and monetizes podcasts. The Podglomerate is a boot-strapped organization which now works with more than 70 podcasts and more than 30 million monthly podcast downloads. Jeff has written for and been quoted in Bloomberg, Morning Brew, Adweek, Quartz, Hot Pod, Paste, The Daily Dot, and more. Prior to launching the Podglomerate, Jeff had his hands in audience growth and business development for companies like Product Hunt, Serial Box, VotePlz, Talkshow, and Goldberg McDuffie Communications.About Podglomerate:The Podglomerate has been producing, distributing, and monetizing podcasts since 2016. Now representing more than 70 podcasts accounting for over 30 million monthly downloads, The Podglomerate's clients have topped the podcast charts and have received features on every major podcast distribution app and national coverage in print, digital, radio, and television. The Podglomerate has worked with Freakonomics Radio, PBS, NPR, A+E, Lifetime, History Channel, Harvard Business School, MIT, Stanford, Lit Hub Radio, NPR stations (including KPCC/LAist, NHPR, WHYY, WUNC, VPM, WPM, GBH), WNET, Substack, Magnificent Noise, Expedia, Optum, CVS Health, Hubspot, and Hoff Studios, among many others.Apply to be a Guest on The Thoughtful Entrepreneur: https://go.upmyinfluence.com/podcast-guestLinks Mentioned in this Episode:Want to learn more? Check out Podglomerate website athttps://podglomerate.com/Check out Podglomerate...

For years, health systems have been holding their breath to see if patient volumes would finally return to pre-pandemic levels. Because—per conventional wisdom--if volumes return, then so will operating margins. Right? Not so fast. In this episode, host Abby Burns invites Advisory Board experts Sebastian Beckmann and Elizabeth Orr to explore why with the positive volume forecast we see in our projections won't automatically translate to a healthy financial outlook. Later, Optum Advisory expert Alex Kist joins the group to share what it's looked like to help one health system put their local data into action to achieve the kind of differentiated growth our experts have been touting. Links: Market Scenario Planner 3 ways Boulder Community Health became a provider of choice for CV care Revolutionizing cardiology at Boulder Community Health Ep. 221: How will health system growth look different in 2025 and beyond? Healthcare Consulting Services | Optum Advisory Advisory Board's 7 key factors for future volume growth Charted: The financial gap between rich and poor hospitals grows If you are looking for hands-on support, email us at podcasts@advisory.com or learn more about how Advisory Board can help. Join 165,000+ healthcare leaders and get the industry's most important news in your inbox—every day. Strategic Planner's survey 2024 Survey insights: 6 priorities for health system strategists in 2024 Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent. A transcript of this episode as well as more information and resources can be found on www.advisory.com/RadioAdvisory.

In this podcast episode, Dr. Jonathan H. Westover talks with Jonathan Hunt Glassman and Joshua Lee about digital health innovations in addiction treatment. Jonathan Hunt Glassman - A healthcare entrepreneur and CEO of Oar Health, an addiction recovery platform that is revolutionizing the way people approach Alcohol Use Disorder (AUD) treatment. With over 15 years of experience in the healthcare industry, including strategic leadership roles at Humana, Optum, and Bain & Company, Jonathan combines his expertise with a personal journey of overcoming alcohol addiction to make a meaningful impact in the field of addiction and recovery. Joshua Lee specializes in medication-assisted treatment of alcohol and opioid use disorders. He conducts clinical trials and treats patients struggling with addiction as a primary care physician. As a Professor at NYU Grossman School of Medicine, he leads the Addiction Medicine Fellowship and conducts research focused on justice and community outcomes. He is ready to explore the intersection of addiction treatment with innovative solutions, and personal and professional growth. Check out all of the podcasts in the HCI Podcast Network!

It's In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: The FTC sues PBMs over insulin pricing, a new CGM is approved in Europe, more news about GLP-1s but some research says it may not work as well for one population, diabetes camps are invited to apply for grants, and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients towards higher priced insulin in order to reap millions of dollars in rebates from pharmaceutical companies. The case accuses UnitedHealth Group Inc's (UNH.N), opens new tab Optum unit, CVS Health Corp's (CVS.N), opens new tab CVS Caremark and Cigna Corp's (CI.N), opens new tab Express Scripts of unfairly excluding lower cost insulin products from lists of drugs covered by insurers. The three companies said in statements that the suit was baseless and defended their business practices, saying that they had lowered insulin prices for businesses, unions and patients. https://www.reuters.com/business/healthcare-pharmaceuticals/us-ftc-sues-drug-gatekeepers-over-high-insulin-prices-2024-09-20/ XX A new study finds metformin, may slow aging. Previous studies on "lower order" species have found that it can delay the onset of age-related diseases.  Gotta say, this is only in animal studies right now, not people, human trials are next. https://www.cbsnews.com/boston/news/diabetes-drug-metformin-aging/ XX New research from the Case Western Reserve University School of Medicine identifies a potential new approach to address the opioid overdose epidemic—which has devastated families and communities nationally.   The study, published in the journal JAMA Network Open, suggests semaglutide is linked to lower opioid overdoses in people with opioid-use disorder (OUD) and type 2 diabetes (T2D).   Semaglutide, a glucagon-like peptide receptor (GLP-1R) molecule that decreases hunger and helps regulate blood sugar in T2D, is also the active component in the diabetes and weight-loss drugs Wegovy and Ozempic.   The research team—led by biomedical informatics professor Rong Xu—analyzed six years of electronic records of nearly 33,000 patients with OUD who also had T2D. The researchers used a statistical approach that mimics a randomized clinical trial.   They found patients prescribed semaglutide had a significantly lower risk for opioid overdose, compared to those who had taken any of eight other anti-diabetic medications, including other types of GLP-1R-targeting medications.   About 107,500 people died from drug overdoses nationally in 2023, mostly from opioids, according to the CDC. Despite effective medications to prevent overdoses from OUD, the CDC estimates only a quarter of those with OUD receive them and about half discontinue treatment within six months. https://medicalxpress.com/news/2024-09-popular-diabetes-weight-loss-drug.html XX New research analyzing the effects of two drugs used to treat type 2 diabetes indicates a consistent lack of cardiovascular and renal benefits in Black populations. The drugs, called sodium-glucose co-transporter 2 inhibitors (SGLT2-Is) and glucogen-like peptide 1 receptor agonists (GLP1-RAs), are some of the newer treatments prescribed to lower blood sugar levels in people with type 2 diabetes. The research findings, published in the Journal of the Royal Society of Medicine, show that for White and Asian populations, SGLT2-Is and GLP1-RAs have beneficial effects on blood pressure, weight control and renal function, and significantly reduce the risk of severe heart problems and kidney disease. However, the research shows no evidence of these beneficial effects in Black populations. ""Whether the differences are due to issues with under-representation of Black populations and low statistical power, or to racial/ethnic variations in the way the body and these drugs interact with each other needs further investigation," said Professor Seidu. "It is therefore important that prescribers don't hasten to deny these newer treatments to Black populations on the back of this research." https://www.news-medical.net/news/20240923/Research-reveals-disparities-in-diabetes-drug-efficacy-for-Black-populations.aspx XX If a woman is already in a "prediabetic" state in her teen or college years, her odds for a serious complication of pregnancy later in life rises, new research shows.   Ignoring prediabetes in teenagers "may represent a missed opportunity to avert pregnancy-related complications" later, said study lead author Katharine McCarthy. She's an assistant professor of population health science and policy, and obstetrics, gynecology and reproductive science at the Icahn School of Medicine at Mount Sinai in New York City.   Her team published its findings Sept. 24 in the journal JAMA Network Open. Prior research has found that rates of prediabetes have tripled among Americans ages 12 to 19 over the past decade. In the new study, the Mount Sinai team tracked rates of prediabetes (using blood sugar tests) among a group of 14,000 New York City residents ages 10 to 24. None of these individuals had full-blown diabetes at the time they were tested.   Having prediabetes in youth was linked to a doubling of risk of gestational diabetes -- new-onset diabetes while pregnant. Tracking blood levels of hemoglobin A1c, a measure of a person's average blood sugar level over the prior three months, was very predictive of whether or a not a woman would get gestational diabetes, the team found.   Prediabetes in youth was also linked to an 18% rise in the risk for hypertensive disorders during pregnancy, such as gestational hypertension and preeclampsia, or preterm delivery.   Measuring a teen girl's blood for signs of prediabetes might help protect her against trouble in a later pregnancy, McCarthy's group said. https://www.usnews.com/news/health-news/articles/2024-09-24/prediabetes-in-teens-could-raise-odds-for-complicated-pregnancies-later XX Is there a link between IBD and type 1? In a recent and very large study, researchers looked at more than 630-thousdan people and found that irritable bowel disease seemed to significantly increase the risk of type 1 diabetes and vice versa. Interestingly, patients with IBD were found to have a significantly higher probability of formerly having contracted T1D, validating the bidirectional associations between these comorbidities. The highest risk was observed in patients with ulcerative colitis (aHR = 2.02), highlighting a stronger association with this IBD subtype. Additionally, over 70% of the study cohort was followed for more than ten years, reinforcing the robustness of these findings. https://www.news-medical.net/news/20240919/IBD-increases-type-1-diabetes-risk-revealing-a-bidirectional-link-between-the-two-conditions.aspx XX Roche plans to launch its first continuous glucose monitor (CGM) in Europe “in the coming weeks,” The Accu-Chek Smartguide has European approval for adults with Type 1 or Type 2 diabetes. Roche will roll out the CGM in the Netherlands, Switzerland and Germany. Accu-Chek Smartguide can be worn for 14 days, and features predictive algorithms that Roche hopes will differentiate it from competitors Abbott and Dexcom. However, it also must be calibrated at first using a finger stick, which the other brands don't require.   Roche developed the CGM with three different prediction tools: A feature to predict the risk of low blood glucose within 30 minutes, a feature to forecast glucose levels over the next two hours, and a feature to predict hypoglycemia risk at night.   Pau Herrero, an algorithm and decision support tech lead at Roche, said the device provides a different picture than the trend arrows other CGMs use, which typically forecast glucose levels over the next 20 minutes. The predictions are based on multiple days of patient data using machine learning models. The company is in “active discussions” with the Food and Drug Administration on bringing Accu-Chek Smartguide to the U.S., Moreiras said, adding that he “cannot commit to any timelines.” https://www.medtechdive.com/news/roche-cgm-launch-europe/726863/ XX Exciting news! iLet users can now invite friends and family to join their Bionic Circle to see their diabetes data and receive alerts. By accepting the invite and downloading our new Bionic Circle App, loved ones can monitor an iLet user's CGM values, meal announcements, insulin doses, and alerts from anywhere.   To learn how to invite followers and accept an invite, visit: https://lnkd.in/ghigJKMt XX Diabetes Canada has unveiled the key findings of a first-of-its-kind national survey on how widespread stigma, judgement and discrimination is for those who live with diabetes and the impact of those social experiences on the quality of life for people with diabetes. The survey shows that diabetes can not only negatively impact a person's physical health but can also negatively affect their personal relationships, work or studies, leisure activities, financial situation, and emotional well-being.   In fact, nearly 90% of people living with type 1 diabetes and 70% of people living with type 2 diabetes experience shame and blame for having diabetes.   “As someone who lives with type 2 diabetes, I know first-hand how stigma can negatively impact the quality of life for people living with this condition in Canada,” says Laura Syron, President & CEO of Diabetes Canada. “We need to change the conversation around diabetes—the values, beliefs and language—so that people living with this condition can feel more accepted and understood. These feelings can dramatically improve the likelihood that people living with diabetes can receive the support and care they need to better their health outcomes and their quality of life.” In the survey, key findings show how people living with diabetes must deal with unfair assumptions about what they can and cannot do, judgements if they consume specific foods, and being blamed for having diabetes. 40% of people with T1D never or rarely ask for support to help manage their diabetes when they need it.   56% of people with T2D never or rarely ask for support to help manage their diabetes when they need it.   https://finance.yahoo.com/news/diabetes-canada-releases-first-kind-101300695.html?guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAJIrWwjdye-ehrLNDt-LIGb5qTXaKDTIa8NWwiT7fKwFFgjDMN2nnINis6YfFePWP2ZA2DVYWXEIZQqRlQ4aKLFrYWgvw1jdI-t1n9kO6NIzdBCMXQNNCVl_S-75lDNip2SysHDJQmyqSc4wLjfDya3v9wwTWU-KgE_OqrPCTnlu XX Edgepark commercial XX This is National Glucose Awareness Week. Dexcom and Beyond Type 2 are teaming up for the new designation to encourage people to learn about the importance of glucose and its significant impact on overall health, especially for people with diabetes. The news release says: National Glucose Awareness Week will feature a variety of educational resources about the importance of glucose health and information about new, cutting-edge glucose biosensing technology. That technology is CGM.. now available over the counter as Dexcom's Stelo. Get moving: Participate in a nationwide step challenge (invitation code: glucose) from Sept. 30 to Oct. 13 to help improve your glucose health.† Step challenge participants can register to participate from Sept. 23-29, 2024 and will have the chance to compete for prizes. Get resources: Close the glucose knowledge gap with key educational resources from Beyond Type 2. https://www.businesswire.com/news/home/20240923896101/en/Dexcom-Beyond-Type-2-and-Retta-Establish-National-Glucose-Awareness-Week-to-Close-the-Glucose-Knowledge-Gap?utm_campaign=shareaholic&utm_medium=copy_link&utm_source=bookmark   XX Attention diabetes camp organizers! You're invited to apply for financial support for your need based scholarships. This is the Type 1 Diabetes Camps Project: 2025-2027 Campership Initiative The initiative will also provide limited funds for selected camps to expand their revenue development efforts, funds for professional development and funds for low-income camper recruitment efforts and indirect costs. The initiative is supported by $6 million in grant funding from The Leona M. and Harry B. Helmsley Charitable Trust and $900 thousand in funding from Eli Lilly and Company over the next three years. For more information about the RFP, please login and navigate to the publicly available RFPs: https://newventurefund.force.com/login XX Join us again soon!

In this week's episode, my guest opens up about his personal battle with alcohol misuse and how he ultimately regained control—a journey he now shares with others, offering hope and guidance to those facing similar struggles.Drawing from the lessons learned during his recovery and his business acumen, he founded Oar Health—a telehealth platform designed to support individuals dealing with substance abuse. His story is a testament to the idea that, through resilience and determination, adversity can be transformed into an opportunity to not only reclaim personal power but also to help others do the same.ABOUT OUR GUESTJonathan Hunt-Glassman is the CEO and co-founder of Oar Health. Oar Health is a telehealth platform that simplifies access to medication-assisted treatment for alcohol use disorder. Oar has helped more than 35,000 members get started with safe, effective, FDA-approved medication that helps them drink less or quit alcohol all together. Jonathan founded Oar Health after struggling with alcohol misuse for more than 15 years before taking back control over alcohol with help from medication. Before founding Oar, Jonathan held healthcare strategy leadership roles at Humana, Optum and Bain & Company.Learn more about Jonathan and his work here:http://www.oarhealth.com/podcasthttps://www.linkedin.com/in/jhuntglassman/https://www.facebook.com/OarHealthhttps://x.com/OarHealthhttps://www.instagram.com/OarHealth/ABOUT OUR HOSTKen Eslick is an Entrepreneur, Author, Podcaster, Tony Robbins Trainer, Life Coach, Husband of 35+ Years, and Grandfather. Ken currently spends his time as the President & Founder of The Leaders Lab where he and his team focus on Senior Leadership Acquisition. They get founders the next level C-Suite Leaders they need to go from being an Inc. Magazine 5000 fastest growing company to $100,000,000 + in revenue.  You can learn more about Ken and his team attheleaderslab.coListen to more episodes on Mission Matters:https://missionmatters.com/author/ken-eslick/

Value-based care has been dominating industry conversations in recent years. Here on Radio Advisory, we talk a lot about best practices, how to make the right investments, and how to best prepare leaders for the future of value-based care. But given all this momentum, we want to spend time asking the question: what are the misconceptions or misaligned expectations that leaders have around value-based care? In this episode, host Rachel (Rae) Woods invites Advisory Board value-based care expert Daniel Kuzmanovich and Optum Advisory Service's SVP of value-based care, Erik Johnson, to discuss the mindset shifts they think leaders should be making when pursuing a sustainable value-based care strategy. Throughout the conversation they discuss what leaders are currently getting wrong, how myths about value-based care are impacting the industry, and more. Links: Our Value-based Care playlist Ep. 172: Build a value-based enterprise: Live from 2023 Value-Based Care Summit Ep. 126: [Bonus content] Commercial risk is possible—here's how How Health Plans Can Support Providers in Risk The climb to value-based care 3 strategies for a successful sleep apnea therapy program: Lessons from ENTTX's ASC partnership Strategic Planner's survey 2024 Survey insights: 6 priorities for health system strategists in 2024 Advisory Board is a subsidiary of Optum. All Advisory Board research, expert perspectives, and recommendations remain independent.

All Home Care Matters and our host, Lance A. Slatton were honored to welcome Jonathan Hunt-Glassman CEO and Co-Founder of Oar Health as guest to the show.   About Jonathan Hunt-Glassman:   Jonathan Hunt-Glassman is the CEO and co-founder of Oar Health. Jonathan founded Oar Health after struggling with alcohol misuse for more than 15 years before taking back control over alcohol with help from medication. Before founding Oar, Jonathan held healthcare strategy leadership roles at Humana, Optum and Bain & Company.   About Oar Health:   Oar Health is a telehealth platform that simplifies access to a daily pill to drink less. Oar has helped more than 35,000 members get started with safe, effective, FDA-approved medication that helps them drink less or quit alcohol altogether.

Eric Scheider Eric Scheider is an experienced enterprise architect with a background in healthcare IT. He has worked with major organizations like Humana and Optum, focusing on aligning business strategies with technology solutions. Eric’s career journey has taken him from developer roles to leadership positions, giving him a unique perspective on the challenges and opportunities...

Cory Jenks is the founder of ImprovRx and is a Clinical Pharmacist in Ambulatory Care at Optum. He's a convention-breaking pharmacist, comedian, author, and speaker who combines his healthcare expertise with improv comedy skills to help others adapt to uncertainty and create meaningful connections. Through his innovative approach, books, and performances, he inspires audiences to break free from limiting prescriptions both medical and metaphorical–while finding humor in life's challenges. Today, Cory Jenks shares his unique journey of integrating humor and improv into his roles as a dad and healthcare professional. The conversation explores how a sense of humor can transform parenting challenges into cherished memories and teach resilience through laughter. Cory discusses his background in improv comedy, which he initially pursued to cope with the unpredictability of healthcare, and how it became a vital part of his life. Cory explains key improv principles, such as the "yes, and" technique, demonstrating their application beyond comedy to enhance listening, empathy, and adaptability in daily life. The episode features interactive improv exercises showcasing how these skills can improve interactions with patients, strengthen marriages, and enrich parenting experiences. Listeners will gain insights on incorporating humor and improv techniques to become more present and resilient in their roles as fathers and husbands. Cory's new book, "I Guess I'm a Dad Now," is highlighted as a resource offering practical and hilarious tips for new dads, complementing the episode's engaging and lighthearted discussion. www.thedadedge.com/friday166 www.thedadedge.com/alliance www.linktr.ee/coryjenks Facebook | LinkedIn | Instagram | X | Website

Since 1986 Mr. Vasquez has been the founder of industry changing companies in the United States. A software developer by training, after spending 6 years with AT&T Corporate, Vasquez founded ISAC, a computer consulting firm in 1986. Vasquez wrote the software that automated Ladies Home Journal Magazine in 1987. Until then, the magazine was done on typewriters. Mr. Vasquez merged ISAC into PACE Health Management which developed the first electronic medical record system to go public on NASDAQ that used expert systems and artificial intelligence neural networks to develop clinical pathways that supported clinicians taking patients from admission to discharge. The company was later sold to 3M Healthcare. Mr. Vasquez founded CareMedic Systems – the first real time processing system for hospital Medicare Part A claims. In 2000, the Mayo Clinic Foundation purchased 5% of the company and by 2004, CareMedic software was serving 1,500+ hospitals in America. The company was sold in 2005 to United Healthcare and continues today as a product of Optum. Mr. Vasquez and his wife founded St Gregory Retreat Centers for people suffering from substance abuse. St Gregory developed a proprietary cognitive behavioral therapy (CBT) program and served 10,000+ addicted patients with 25% of those patients addicted to heroin or prescription painkillers. Unique to St Gregory, Mr. Vasquez worked with research physicians to understand, develop, and deliver an intravenous body chemistry solution to reduce or eliminate cravings for opioids. Delivered to over 2,000 patients by 14,000 treatments with almost no adverse effects, the result was 84% of patients were still alive, sober and working after 48 months. To complement this solution, Mr. Vasquez also developed and built a complex mass-spectrometer laboratory with unique panels that could identify metabolites of opioids as recovering patients required undeniable oversite. The company was  sold to a venture capital roll-up, Summit BHC in September 2018.After interviewing hundreds of opiate and heroin addicted patients, Vasquez saw a constant theme where patients had become dependent due to prescriptions provided for acute or chronic pain, primarily orthopedic in nature. In an effort to reduce opioid prescribing, Vasquez founded Harbor View Medical, which provided orthopedic stem cell procedures developed by Regenexx© as a non-invasive alternative for people who were facing orthopedic surgery and potential long-term opioid prescriptions. Mr. Vasquez was successful in getting local self-insured health plans to include coverage for these procedures. Harbor View Medical was merged into Regenexx© in 2017.In January 2018, Opioid Clinical Management, Inc was founded by Mr. Vasquez in response to the dramatic opioid epidemic and the national need for a solution. OPCM has developed proprietary software algorithms (patent pending) and integrated provider management to allow large self-insured employers to identify physicians who are over-prescribing opioids and employees that are struggling from resulting opioid abuse. There are 1,700 employer health plans that use OPCM software. In 2000 Mr Vasquez was named Ernst & Young “Entrepreneur of the Year” and inducted into the Entrepreneur of the Year “Hall of Fame'' He received his Executive Health Management Certificate, Harvard School of Public Health and attended the U.S. Air Force Academy and Drake University.Topics covered in this episode:Opioid Addiction Treatment StrategiesEarly Intervention Opioid Addiction DevelopmentDefinitions of AddictionWithdrawal Symptoms Treatment ApproachesPersonal Motivation and JourneyRole of Faith in RecoveryReferenced in the episode:The Lindsey Elmore Show Ep 276 | Why Drug Prices Keep Rising: Pharmacists Perspectives | Patrick DevereuxThe Lindsey Elmore Show Ep 174 | Overcoming Political Influence on Healthcare | John AbramsonTo learn more about Michael Vasquez and his work, head over to www.michael-vasquez.com__________________________________________________________In Michael Vasquez's books, he allows readers to explore the complex challenge that is posed by the opioid crisis in the United States. We talk everything from healthcare innovation to drug treatments, border control policies, and how we can be more innovative with tools like artificial intelligence to determine if drugs are being abused.Helping prevent just one more opiate related death in the United States is enough. If you would like to learn more about what you can do in your daily life, to help prevent the opioid crisis from getting worse, head to lindseyelmore.com/opioid to purchase Michael's book, The Untold Story of the Opioid Crisis in American Healthcare and The New Era of Prevention Through AI.__________________________________________________________We hope you enjoyed this episode. If you would like to be a supporter of the show, head to www.lindseyelmore.com/supporter Your contribution helps us to bring the best guests into our interview chair. Thank you for listening. Come check us out at www.spreaker.com/show/the-lindsey-elmore-showBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-lindsey-elmore-show--5952903/support.